These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 15234645

  • 21. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ.
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
    [Abstract] [Full Text] [Related]

  • 22. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.
    Goei Thè HS, Lund B, Distel MR, Bluhmki E.
    Osteoarthritis Cartilage; 1997 Jul; 5(4):283-8. PubMed ID: 9404473
    [Abstract] [Full Text] [Related]

  • 23. Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis.
    Girawan D, Abdurachman SA, Djumhana A, Roslia J, Pramudiyo R.
    Acta Med Indones; 2004 Jul; 36(4):202-6. PubMed ID: 15673949
    [Abstract] [Full Text] [Related]

  • 24. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac.
    Dreiser RL, Le Parc JM, Vélicitat P, Lleu PL.
    Inflamm Res; 2001 Mar; 50 Suppl 1():S17-23. PubMed ID: 11339516
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators.
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis.
    Chang DM, Young TH, Hsu CT, Kuo SY, Hsieh TC.
    Clin Rheumatol; 2001 Mar; 20(2):104-13. PubMed ID: 11346221
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
    Euller-Ziegler L, Vélicitat P, Bluhmki E, Türck D, Scheuerer S, Combe B.
    Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
    [Abstract] [Full Text] [Related]

  • 36. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.
    Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C.
    Inflamm Res; 1995 Oct; 44(10):423-33. PubMed ID: 8564518
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.